MedTrace Logo

Hemo Filtration Reinfusion (HFR) Clearance Efficiency Towards P-bound Toxins and Effects on Inflammatory and Endothelial Damage Markers

NCT02240004 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2015-03-30

No results posted yet for this study

Summary

The aim of this study is to compare purification efficiency of HFR in terms of clearance of protein-bound toxins and the effects on markers of inflammation and endothelial damage, in comparison to HF-HD and OL-HDF.

Conditions

Interventions

DEVICE

SUPRA HFR

usual dialytic prescription for duration, frequency, acid buffer and anticoagulation regimen

Sponsors & Collaborators

  • Hospital Universitario Reina Sofia de Cordoba

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-02-28
Completion
2015-03-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02240004 on ClinicalTrials.gov